Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

The Efficacy of Hypericum perforatum (St John's Wort) for the Treatment of Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

By Canning Sarah  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 207-225

Adis International

Access to resources Recommend Favorite

A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint

By William Hanke C.   Narins Rhoda S.   Brandt Fredric   Cohen Joel L.   Donofrio Lisa M.   Downie Jeanine   Heinz Moritz   Harrington Laura   McDaniel David H.   Nestor Mark   Schlessinger Joel   Schlöbe Andrea   Taub Amy   Weiss Robert A.  

Dermatologic Surgery, Vol. 39, Iss. 6, 2013-06 ,pp. : 891-899

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Adjunctive Zonisamide in Adult Patients with Refractory Partial-Onset Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Trial

By Lu Yang   Xiao Zhanqin  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 221-229

Adis International

Access to resources Recommend Favorite

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

By Negi Sanjay   Agarwal Anil   Chaudhary Adarsh  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite